当前位置: 首页 > 详情页

MicroRNA-322 attenuates aluminum maltolate-induced apoptosis in the human SH-SY5Y neuroblastoma cell line

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053 [2]School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069 [3]Human Anatomy Division, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China
出处:
ISSN:

关键词: microRNA-322 aluminum-maltolate apoptosis V-Myc avian myelocytomatosis viral oncogene homolog Alzheimer's disease

摘要:
Aluminum-maltolate (Al-Malt) is a potent apoptosis inductor, which has been widely reported as an etiologic factor in Alzheimer's disease (AD). MicroRNA-322 (miR-322) is a vital regulator in various biological processes. The aim of the current study was to identify the role and possible underlying mechanism of miR-322 in Al-Malt-induced apoptosis. Eight concentrations of Al-Malt were prepared and used for treating the human neuroblastoma cell line, SH-SY5Y. Subsequent to treatment with Al-Malt for 3 days, cell viability, apoptosis and the expression levels of apoptosis-associated factors were measured. In addition, the mRNA expression level of miR-322 was monitored. Furthermore, cells were transfected with an miR-322 mimic and/or treated with Al-Malt, and cell viability, apoptosis and the expression levels of apoptosis-associated factors were measured again. Al-Malt significantly inhibited cell viability, but promoted apoptosis. The apoptosisassoci-ated factors, V-Myc avian myelocytomatosis viral oncogene homolog (c-Myc), Bcl-2-associated X protein, caspase-3 and cleaved caspase-3 were markedly upregulated by Al-Malt. The mRNA expression level of miR-322 was negatively regulated by Al-Malt. Furthermore, miR-322 attenuated the apoptosis induced by Al-Malt and recovered the expression changes of these four factors. Thus, miR-322 may attenuate Al-Malt-induced apoptosis by recovering the expression change of c-Myc. Furthermore, miR-322 may be involved in the pathogenesis of Al-Malt-associated AD.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2015]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053
共同第一作者:
通讯作者:
通讯机构: [*]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, N45 Changchun Street, Xicheng, Beijing 100053, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院